# Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound

> **NCT02044523** · — · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 108 (actual)

## Conditions studied

- Hepatitis C
- Hepatitis B
- Nonalcoholic Fatty Liver Disease (NAFLD)
- Nonalcoholic Steatohepatitis (NASH)

## Interventions

- **DEVICE:** Transient elastography, acoustic radiation force impulse, magnetic resonance elastography

## Key facts

- **NCT ID:** NCT02044523
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2018-09-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02044523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02044523, "Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02044523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*